Herlev Hospital - PARENT

Herlev

0 studies enrolling now · 1 studies all time

What they study most

Advanced Solid Tumors

Studies at this site

• Phase 1 Trial of MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Combination With Radiotherapy — Completed